amino-acid peptide (rCST14), also called cortistatin, or Cortistatin is a 14-residue putative neuropeptide at both sites to generate both CST14 and a 13-residue with strong structural similarity to somatostatin and is peptide (Fig. 1) . rCST14 shares 11 of its 14 residues expressed predominantly in cortical GABAergic inter-with somatostatin, including those that are known to neurons of rats. Administration of cortistatin into the be responsible for somatostatin binding to its receptors brain ventricles specifically enhances slow-wave sleep, (Veber et al., 1979) and the cysteines that are likely presumably by antagonizing the effects of acetylcholine to render the peptide cyclic. The 13-residue species is on cortical excitability. Here we report the identifica-unrelated to known proteins. Preprocortistatin mRNA tion of cDNAs corresponding to mouse and human pre-is expressed in a distinct subset of interneurons in the procortistatin and the mRNA distribution and gene rat cerebral cortex and hippocampus, areas of the brain mapping of mouse cortistatin. Analysis of the nucleo-thought to be important for high cognitive functions tide and predicted amino acid sequences from rat and (de Lecea et al., 1996) . The cDNA sequences of prepromouse reveals that the 14 C-terminal residues of precortistatin and preprosomatostatin indicate clearly procortistatin, which make up the sequence that is that they are the products of separate genes.
INTRODUCTION
whereas somatostatin is known to enhance acetylcholine release and to potentiate acetylcholine responses We recently isolated a cDNA clone of the mRNA en- (Mancillas et al., 1986) . These observations demoncoding rat preprocortistatin, a 112-residue protein, the strated that cortistatin is functionally distinct from soamino acid sequence of which suggests that it is the matostatin and raised the possibility that cortistatin putative precursor of a novel secreted neuropeptide (de exerts its activities through an uncharacterized corti- Lecea et al., 1996) . Maturation of the rat preprospecies statin-selective receptor, although other explanations to procortistatin would produce a protein that could be of different functionalities can be considered. processed at a Lys-Arg site to generate a 29-residue To gain information on the conservation of the pupeptide (rCST29), at a Lys-Lys site to give rise to a 14-tative processed neuropeptides, we have isolated cDNA clones encoding mouse and human preprocor-1 To whom correspondence should be addressed at the Department tistatin. We demonstrate that the amino acid se- 
grams of poly(A)
/ RNA from rat, mouse, and human (Clontech) samples was run on formaldehyde agarose gels and transferred to nylon filters as described . Mouse or human cDNA probes were labeled with 32 P and random primers. In situ hybridization. C57BL/6J mice were perfused with 4% paraformaldehyde and processed for in situ hybridization as described (de Lecea et al., 1994) . Free-floating sections were hybridized with 10 7 cpm/ml labeled cortistatin probe and washed at 60ЊC in 0.51 SSC/50% formamide for 3 h. After being mounted, slides were dipped in Ilford K5 emulsion diluted in water and exposed for 3 weeks at 4ЊC. Slides were developed in Kodak D19, counterstained, and mounted in Permount.
Chromosomal mapping. The oligonucleotides for mapping Cort by SSCP were 5-AAAAAGCCCTGCAAGAACTT-3 (Cort1F) and 5-ATTCAGGTCTCGTTGGCATC-3 (Cort1R). The PCR conditions have been described previously (Dietrich et al., 1992) except that [a-32 P]dCTP was incorporated into the reaction. The PCR product was denatured, then quick cooled on ice and electrophoresed for 4 h in a 0.5% MDE gel (AT Biochem, Inc.) at 4ЊC. The gel was exposed to Xray film overnight. Linkage data were analyzed using the latest version of the computer program MapManager (Manly and Elliott, 1991) , which can be obtained on the web (http://mcbio.med.buffalo.edu/mapmgr.html). The sequence of the Cort PCR product was determined by the dideoxy method using Cort1F and Cort1R primers.
RESULTS

Analysis of Mouse Preprocortistatin DNA Sequence
We previously reported the isolation of a rat cDNA clone, the nucleotide sequence of which suggested that it encoded the precursor of cortistatin, a peptide with sequence similarity to somatostatin. Preprocor-FIG. 1. Schematic drawing (not to scale) showing the structure tistatin begins with a 27-residue apparent secretion of the rat, mouse, and human cDNAs encoding preprocortistatin and signal sequence. Interestingly, this region contains putatively processed fragments. The putative cleavage sites by prosix iterations of the trinucleotide CTG, whose triplet hormone convertases have been indicated (RR, KR, KK, and RK). expansion in other genes has been implicated as Putative products are labeled by species (r, m, and h) and predicted causal in neurological diseases (e.g., myotonic dystroamino acid length in the absence of further processing (e.g., rCST14). phy) (Brook et al., 1992) . The rat preprocortistatin deduced amino acid sequence contains several pairs conserved in mouse. Lack of sequence conservation of basic residues that are possible substrates of profor the 13-residue peptide suggests that it may not hormone convertases. Cleavage at all basic amino be an active proteolytic product of preprocortistatin. acid pairs would give rise to rCST17 (with a putative In addition, we have mapped the gene to mouse chro-amidation site), rCST31, rCST29, rCST13, and mosome 4, in a region syntenic to human chromosome rCST14 (Fig. 1) . Alternative or partial cleavage could 1p36. The human putative cortistatin peptide has an produce additional peptide products. rCST14 may be arginine for lysine substitution, compared to the rat further processed by carboxypeptidases that would and mouse products, and is N-terminally extended remove its C-terminal lysine. by 3 amino acids.
We used the full-length rat cDNA clone to screen a mouse cerebral cortex cDNA library (generously provided by Dr. K. Hasel). Several positive clones were
MATERIALS AND METHODS
isolated, and their nucleotide sequences were deter-DNA cloning and sequencing. A mouse (C57BL/6J) cortex DNA mined. Two cDNA clones, 430 bp long, appeared to be library (kindly provided by K. Hasel) was screened with the fullfull-length as judged by the alignment of their 5 ends length rat cortistatin DNA. Replica filters containing 1.5 1 10 5 colo-with the rat sequence (not shown). After introduction nies (30 plates of 5000 each) were washed at moderate stringency of two gaps, the mouse and rat nucleotide sequences (11 SSC, 68ЊC) . After several rounds of screening we isolated five were 86% identical ( Fig. 2A) . Assuming that the putapositive clones, and the sequence of the longest was determined by the dideoxy chain termination method. Human preprocortistatin tive mouse translation initiation product begins at the cDNA was amplified by PCR using primers to the C-terminal se-second methionine triplet, it contains 108 amino acids quence of cortistatin. The PCR fragment was cloned, random prime compared to 112 for rat. Again, after introduction of labeled, and used to screen a cDNA library prepared from human two gaps, the putative rat and mouse proteins share whole-brain mRNA (Clontech, Palo Alto, CA).
82% identity (Fig. 2B) . The mouse nucleotide sequence
Northern blot. Cytoplasmic poly(A)
/ RNA was isolated from rat and mouse brains as described (Schibler et al., 1980) . Two microcorresponding to rCST14 and the adjacent lysine dou-much lower degree of identity to the rat sequence (71%). The human preprocortistatin deduced amino acid sequence (Fig. 2B ) has 114 residues and begins with a 29-amino-acid hydrophobic probable secretory signal sequence. The sequence corresponding to the putative signal peptide of preprocortistatin contains only four iterations of CTG encoding the amino acid leucine, in contrast to six iterations of the same triplet in the rat peptide precursor or three in mouse, suggesting that this sequence is unstable and subject to expansion. Analysis of the putative processing sites in human preprocortistatin revealed that it may be cleaved at two RR sites, giving rise to hCST29 and a C-terminal 17-residue peptide that shared 13 of the last 14 residues with rat and mouse CST14, here called hCST17. The Lys-Lys pair that lies just N-terminal to cortistatin-14 in rat and mouse is not conserved in the human sequence. The other possible products that follow the signal sequence (hCST21 and hCST31) are not very conserved across species, although rCST31 and hCST31 share 13 residues clustered in their N-terminal regions
FIG. 2-Continued
that are conserved among the rat, mouse, and human prohormone sequences (Fig. 2B) . blet that putatively serves as its site of proteolytic remRNA Expression lease from its precursor were identical to the same region in the rat sequence, thus supporting a functional
We determined the distribution of preprocortistatin conservation of the mature peptide. The DNA sequence mRNA by Northern blot. A band of approximately 600 upstream of the processing site of mCST14 showed sev-nucleotides was detected in samples prepared from rat eral points of divergence, including some resulting in brain, cortex, and hippocampus, but not pancreas or nonconservative amino acid substitutions. Two of these gut (Fig. 3) or adrenal gland, liver, spleen, thymus, differences obliterate pairs of basic residues (Figs. 1 ovary, testes, or anterior pituitary (not shown). This and 2B), suggesting that CST14 is the only active pep-pattern of expression is clearly distinct from somatotide processed from both the rat and the mouse precur-statin mRNA, which is present in several endocrine sors.
tissues. Hybridization to Northern blots of mouse tissues revealed the presence of two bands in brain but Cloning of Human Preprocortistatin not liver, kidney, or thymus. Two bands were also observed in the human brain sample. These bands are To isolate a DNA clone encoding human preprocortistatin we used a combination of PCR and conventional probably due to alternate polyadenylation signals, found to be present in mouse genomic clones (L.dL., screening techniques. We isolated a 120-bp fragment of the human coding sequence by PCR using degenerate unpublished observations) and in human cDNA clones.
We previously reported that rat cortistatin is exprimers from the mouse and rat sequences. The nucleotide sequence of this fragment was compared to the pressed in a subset of cortical and hippocampal GABAergic interneurons. To determine whether the ex-EST database, and one sequence was found with significant similarity to cortistatin, although several gaps pression of cortistatin was conserved between species, we performed in situ hybridization with mouse brain were required for alignment. We then designed primers to amplify a 250-nucleotide fragment that was used as tissue (Fig. 4) . As in the rat, cortistatin-positive neurons were enriched in the cerebral cortex and hippoa probe to screen a human whole-brain cDNA library. From several rounds of screening we isolated two cDNA campus. In the temporal/visual cortex, cortistatin-positive neurons were especially abundant in layer VI, with clones, 450 and 270 nucleotides in length, and the sequence from the longest was determined.
very few scattered cells present in layer II-III (Figs. 4A and 4B). In the hippocampus, preprocortistatin mRNA The human nucleotide sequence ( Fig. 2A) showed a   FIG. 2. (A) Alignment of the nucleotide sequences of rat, mouse, and human preprocortistatin cDNAs. The human sequence is a composite from different PCR fragments and cDNA clones, including one that showed a deletion in the coding sequence and an additional 3 polyadenylation signal. The CTG repeat that encodes the amino acid leucine and that is of variable length between species has been underlined. The two possible polyadenylation signals are marked with an asterisk. Nucleotides conserved among all three species are shown in uppercase, otherwise, in lowercase. (B) Alignment of the deduced amino acid sequences of the rat, mouse, and human cortistatin precursors. The putative dibasic cleavage sites are indicated in bold. Consensus residues are indicated. (C) Comparison of the amino acid sequences and predicted secondary structures of rat, mouse, and human cortistatin and somatostatin from frog and mammals.
FIG. 3.
Northern blots of RNA samples from rat whole brain, cortex, hippocampus, gut, and pancreas and mouse brain, liver, thymus, and kidney. The blots were hybridized with the rat cortistatin cDNA and with a cyclophilin probe (Danielson et al., 1988 ; not shown) as a control for loading and RNA integrity. A separate Northern blot containing an mRNA sample from whole human brain was hybridized with the human preprocortistatin cDNA sequence. In short exposures both the mouse and the human samples displayed two bands, pobably generated by alternative polyadenylation signals.
could be visualized in the stratum oriens of the CA1-logical disorders mapping to this region for which Cort would be a compelling candidate. CA3 fields, as well as in a few neurons adjacent to the granule cell layer of the dentate gyrus. The hilar region was totally devoid of preprocortistatin-expressing cells.
DISCUSSION
Strong signals could also be detected in the amygdala, especially in the medial amygdaloid nucleus (Fig. 4C) .
We have described the cloning of the mouse and In the hypothalamus, preprocortistatin mRNA was dehuman homologues of the neuropeptide cortistatin tected in a few cells in the periventricular nucleus. mRNAs and mRNA distribution and gene mapping of mouse preprocortistatin. Analysis of the nucleotide and Chromosomal Mapping of Mouse Cortistatin predicted amino acid sequences from rat and mouse reveals that the 14 C-terminal residues of preprocortiWe mapped the cortistatin gene (gene symbol Cort) by single-strand conformation polymorphism analysis statin, which constitute the sequence that is most similar to somatostatin, are conserved between these speof a panel of interspecific backcross mouse DNAs. We designed primers that spanned the 3 coding/3 un-cies, whereas the mono-or dibasic amino acid residues whose cleavage by prohormone convertases would give translated sequence of mouse cortistatin cDNA and amplified the corresponding 107-bp genomic fragment rise to additional peptides are not conserved. This strongly suggests that CST14 is the only active peptide from C57BL/6J (B6) and a strain inbred from wildderived Mus spretus (SPRET/Ei). Representative PCR derived from the precursor, although other species-specific peptides may be produced. fragments were sequenced to confirm their identity. A clear polymorphism that distinguished the two strains From the known members of the family of precursor convertases, only furin, PC1, and PC2 are expressed was found. To determine linkage the segregation pattern of the B6 allele was followed in a subpanel of 54 at significant levels in neurons (Seidah and Chretien, 1994) . Furin normally cleaves precursors entering the (B6 1 SPRET) F1 1 SPRET backcross offspring and compared to that of over 2500 genes previously mapped constitutive pathway and has strong substrate specificity. In general, the available cleavage specificity data on the panel. The mouse cortistatin locus was found to lie on distal chromosome 4-in contrast with the demonstrate that both PC1 and PC2 prohormone convertases cleave precursors at single and pairs of basic somatostatin gene which maps to chromosome 16 (Lalley et al., 1987) -and was nonrecombinant with the residues and that the four combinations KR, RR, RK, and KK are possible cleavage sites for these enzymes Mtfhr locus (LOD 16.3; Fig. 5 ). Neurological mutations that are known to reside in this region include Wal-(Seidah and Chretien, 1994) . In the mouse preprocortistatin cDNA sequence, the only processing site that is lerian degeneration (Wld) and jerker (je). A quantitative trait locus for b-carboline-induced seizures has conserved with rat is the one that gives rise to CST14.
Interestingly, the arginine from the KR site that would also been mapped in this region (Martin et al., 1995) . This telomeric region of mouse Chr 4 show strong con-produce CST29 in rat is substituted by a serine in mouse, generating a KS sequence, a very unlikely subserved synteny with human chromosome 1p36 (O'Brien et al., 1993), but we have not identified human neuro-strate for convertases. Even though the KK site is not cortistatin-14 sequence with one conservative substitution. This suggests that the critical amino acids for cortistatin function reside in the loop formed by the two cysteines and, possibly, in the N-terminal proline and C-terminal lysine, although the latter may be processed by carboxypeptidases in the secretory pathway (Fricker, 1988) . We cannot rule out the possibility that the human CST species is further processed at a single R site, to generate CST14 with an additional N-terminal methionine substitution. Recently, a second vertebrate somatostatin gene has been reported in the frog Rana ridibunda (Tostivint et al., 1996) . Frog somatostatin II has two amino acid substitutions relative to somatostatin I: a Pro at position 2 and a Met at position 13 (Fig. 2C) . Thus, the Nterminal proline residue may be critical for the specific actions of somatostatin II in frog and cortistatin in rat, mouse, and human. However, somatostatin II is an unlikely predecessor of cortistatin, as the nucleotide and amino acid sequences of the precursors are quite divergent. As during the evolution of tetrapods several gene duplications may have occurred, the existence of more members of the somatostatin/cortistatin family in mammals cannot be ruled out.
Analysis of mouse preprocortistatin mRNA expression showed an overall coincidence with the pattern described in rat. However, mouse preprocortistatin mRNA seems less abundant than its rat counterpart, as judged by Northern blot and in situ hybridization. In the mouse visual cortex, cortistatin-positive cells were abundant only in the deep layers, whereas in rat, cortistatin signals covered the entire thickness of the cortex. Also, we could detect some cortistatin-positive cells in the mouse periventricular hypothalamic area and in the amygdala, regions that were negative in the rat. six repetitions of the trinucleotide CTG in the region corresponding to its putative signal peptide, whereas a preferred substrate for PC1 or PC2, there are exam-the mouse sequence contains three and the human disples in the literature of such cleavage, especially plays four iterations of the same triplet. The instability in cells of neural origin. For example, PC1 has been of CXG repeats has been shown to be responsible for shown to cleave human proenkephalin at a Lys-Lys several neurological diseases in humans as well as in site (Mathis and Lindberg, 1992) . Also, b-endorphin mouse models. Expansion of the CTG repeat of cortican be efficiently cleaved at its Lys 28 -Lys 29 site in arcu-statin would likely impair its processing into a mature, ate hypothalamic neurons, generating a potent endoge-active peptide. Alternatively, an expanded polyleucine nous opioid antagonist (Zakarian and Smyth, 1982) . stretch could produce gain-of-function mutations. Furthermore, the KK site in the N-terminus of b-melanin-stimulating hormone can be generated from proopiomelanocortin by PC2 cleavage in the intermediate ACKNOWLEDGMENTS lobe of the pituitary (Lin et al., 1993) .
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rise to a 17-residue peptide that contains the active Somatostatin, glucagon, calcitonin and parathyroid hormone. Cy-
